Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v7-EN
Language English English
Date Updated 2017-12-05 2017-11-20
Drug Identification Number 02399229 02399229
Brand name PROQUAD PROQUAD
Common or Proper name measles, mumps, rubella and varicella virus vaccine live Lyophilized powder for injection measles, mumps, rubella and varicella virus vaccine live Lyophilized powder for injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients MUMPS VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED MUMPS VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED
Strength(s) 4.30Log10 TCID50 3.99Log10 PFU 3.00Log10 TCID50 3.00Log10 TCID50 4.30Log10 TCID50 3.99Log10 PFU 3.00Log10 TCID50 3.00Log10 TCID50
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 0.5ML 10 X 1 DOSE VIAL 0.5ML 10 X 1 DOSE VIAL
ATC code J07BD J07BD
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-12-01 2017-11-24
Actual start date
Estimated end date 2017-12-08 2017-12-01
Actual end date 2017-11-30
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments